Adagio Therapeutics shares are trading higher after traders circulated rumors of a reiterated Buy rating and $46 price target from Jefferies.
Watching Adagio Therapeutics Shares Following US Patent & Trademark Office Abstract For Co.'s 'COMPOUNDS SPECIFIC TO CORONAVIRUS S PROTEIN AND USES THEREOF'
Benzinga - 17 minutes ago
rumors? oh boy, this is going to gap down...oops...
No comments:
Post a Comment